Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/11/1998 | EP0876389A1 Therapeutic compounds |
11/11/1998 | EP0876388A1 Tricyclic erythromycin derivatives |
11/11/1998 | EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors |
11/11/1998 | EP0876386A1 Water soluble antibiotics |
11/11/1998 | EP0876376A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
11/11/1998 | EP0876356A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
11/11/1998 | EP0876353A1 Retroviral protease inhibiting compounds |
11/11/1998 | EP0876336A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
11/11/1998 | EP0876157A1 Methods and compositions for passive immunotherapy |
11/11/1998 | EP0876153A2 Medical use of proteases |
11/11/1998 | EP0876150A1 Non-toxic mutants of pathogenic gram-negative bacteria |
11/11/1998 | EP0876148A1 Sphingolipids effective against bacteria, parasites, protozoans, fungi and viruses |
11/11/1998 | EP0876146A1 Nucleoside analogs in combination therapy of herpes simplex infections |
11/11/1998 | EP0640074B1 Salts of a quinolone-carboxylic acid |
11/11/1998 | EP0579826B1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
11/11/1998 | CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
11/11/1998 | CN1198741A Imidazole derivatives having affinity for alpha 2 receptors activity |
11/11/1998 | CN1198669A Use of aminoadamantane compound as immunoregulators |
11/11/1998 | CN1198341A Prescription of ointment for curing onychomycosis and preparation method thereof |
11/11/1998 | CN1198330A Method for treating protozoal infections |
11/11/1998 | CN1040646C Enatiomeric hydroxylated xanthine compound |
11/10/1998 | US5834587 G-protein coupled receptor, HLTEX 11 |
11/10/1998 | US5834586 Dehydrodidemnin B |
11/10/1998 | US5834506 Treatment of hiv, aids; antiviral activity improved by judicious placement of polar substituents |
11/10/1998 | US5834487 Inhibition of 26S and 20S proteasome by indanones |
11/10/1998 | US5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity |
11/10/1998 | US5834469 Endothelin receptor antagonists |
11/10/1998 | US5834467 HIV protease inhibitors |
11/10/1998 | US5834450 Doxycycline analogs, effective against organisms resistant to tetracyclines |
11/10/1998 | US5834443 Composition and method for treating herpes simplex |
11/10/1998 | US5834441 Introducing a genetic sequence into a host cell |
11/10/1998 | US5834438 Enhancement of gastric motility, prokinetic agents |
11/10/1998 | US5834419 Chemokine binding protein and methods of use therefor |
11/10/1998 | US5834307 Recombinant polynucleotide which codes for a polypeptide from a cytomegalovirus glycoprotein; for vaccines, diagnosis |
11/10/1998 | US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus |
11/10/1998 | US5834186 Regulatable RNA molecule |
11/10/1998 | US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same |
11/10/1998 | US5834004 Enteral composition comprising dimethicone and a photosensitizer and a method of delivery |
11/10/1998 | US5833993 Feline immunodeficiency virus vaccine |
11/10/1998 | US5833980 Inoculating poultry, live virus vaccine |
11/10/1998 | CA2050786C An antimicrobial peptide and an antimicrobial composition |
11/07/1998 | CA2231754A1 A novel human g-protein coupled receptor hcept09 |
11/05/1998 | WO1998049346A1 Enzymatic dna molecules |
11/05/1998 | WO1998049334A1 Novel internal ribosome entry site and vector containing same |
11/05/1998 | WO1998049315A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold |
11/05/1998 | WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
11/05/1998 | WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
11/05/1998 | WO1998049288A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
11/05/1998 | WO1998049193A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
11/05/1998 | WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
11/05/1998 | WO1998049177A1 Anti-viral pyrimidine nucleoside analogues |
11/05/1998 | WO1998048840A1 Polyethylene glycol-interferon alpha conjugates for therapy of infection |
11/05/1998 | WO1998048836A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant |
11/05/1998 | WO1998048835A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method |
11/05/1998 | WO1998048828A1 Method of treating sepsis |
11/05/1998 | WO1998048809A1 Use of immunomodulating agents |
11/05/1998 | WO1998039450A3 Surface protein (spsa protein) of streptococcus pneumoniae, deleted derivatives, expression system for said proteins and vaccine system with said proteins |
11/05/1998 | WO1998031786A3 Novel microorganisms |
11/05/1998 | DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
11/05/1998 | CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/05/1998 | CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/05/1998 | CA2289253A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method |
11/05/1998 | CA2288030A1 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold |
11/05/1998 | CA2287976A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant |
11/05/1998 | CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways |
11/05/1998 | CA2287877A1 Method of treating sepsis |
11/05/1998 | CA2258490A1 Novel internal ribosome entry site and vector containing same |
11/04/1998 | EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof |
11/04/1998 | EP0875566A2 Novel G-protein coupled receptor (HFGAN72X) |
11/04/1998 | EP0875565A2 Novel G-protein coupled receptor (hfgan72y) |
11/04/1998 | EP0875501A2 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug |
11/04/1998 | EP0875251A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis |
11/04/1998 | EP0874905A1 Novel tcts response regulator of staphylococcus aureus |
11/04/1998 | EP0874864A1 Osteo antiviral protein |
11/04/1998 | EP0874863A1 3-deoxy-3-descladinose derivatives of erythromycins a and b |
11/04/1998 | EP0874854A2 Cephalosporin antibiotics |
11/04/1998 | EP0874853A1 Process for preparation of cefdinir |
11/04/1998 | EP0874852A1 Oxazolidinone antibacterial agent with tricyclic substituents |
11/04/1998 | EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
11/04/1998 | EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
11/04/1998 | EP0874839A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
11/04/1998 | EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors |
11/04/1998 | EP0874809A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
11/04/1998 | EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
11/04/1998 | EP0874638A1 Hemoregulatory compounds |
11/04/1998 | EP0874633A1 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial |
11/04/1998 | EP0874631A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
11/04/1998 | EP0874621A1 Pharmaceutical compositions |
11/04/1998 | EP0688167B1 Ionene polymers as microbicides |
11/04/1998 | EP0656950B1 Tat-derived transport polypeptides |
11/04/1998 | EP0554446B1 Monoclonal antibodies useful in therapy of HIV-1 infection |
11/04/1998 | CN1198185A Detection, prevention and treatment of papillomatous digital dermatitis |
11/04/1998 | CN1198165A Modulators of function of FAS receptors and other proteins |
11/04/1998 | CN1198164A Novel water-soluble C-ring analogues of 20(s)-camptothecin |
11/04/1998 | CN1198162A Carbapenem antibiotic, composition and method of preparation |
11/04/1998 | CN1198099A Acellular pertussis vaccines and method of preparation thereof |
11/04/1998 | CN1197641A Medicine containing tan matter caesalpinia extract |
11/04/1998 | CN1040541C Preparation of polypeptide compound |
11/04/1998 | CN1040504C Process for preparation of pharmaceutical composition containing triazole derivative |
11/03/1998 | US5831115 Inhibitors of squalene synthase and protein farnesyltransferase |